Clinical Trial Logistics Market Size
| Study Period | 2020 - 2029 |
| Market Size (2024) | USD 170.49 Billion |
| Market Size (2029) | USD 198.42 Billion |
| CAGR (2024 - 2029) | 5.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America and Europe |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Clinical Trial Logistics Market Analysis
The Clinical Trial Logistics Market size is estimated at USD 170.49 billion in 2024, and is expected to reach USD 198.42 billion by 2029, growing at a CAGR of 5.80% during the forecast period (2024-2029).
The increasing number of clinical trial procedures conducted by pharmaceutical companies is expected to significantly impact the clinical trial logistics market. According to data from ClinicalTrials.gov, the United States leads in the number of clinical trials conducted annually. Factors such as the growing presence of contract research organizations (CROs) and healthcare providers are contributing to the market's expansion.
Additionally, the market's growth is driven by the rising demand for Over The Counter (OTC) medications such as Vitamins, Minerals, and Supplements (VMS), common cold remedies, gastrointestinal drugs, and dermatology products.
The growing importance of expedited healthcare assistance is fueling the demand for clinical trial logistics. Furthermore, reducing distribution costs through a centralized distribution channel is boosting the need for these services. Moreover, advancements in pharmaceuticals and biologics, particularly in the testing and development of new products, drugs, and experiments, are major drivers of the global clinical trial logistics market.
The COVID-19 pandemic had a widespread effect on all industries. Clinical trial diagnostic labs were under increased scrutiny as they faced growing pressure to effectively carry out stages of clinical trials for vaccines and treatments to reduce the global health impact of COVID-19.
Clinical Trial Logistics Market Trends
Increasing Specimen Collection From Homes
The evolution of the pharmaceutical industry has led to changes in the nature of clinical trials. The focus is now on evidence-based medicine, patient-centered care, and the development of orphan drugs and personalized cell and gene therapies. This shift has driven the growth of direct-to-patient sample delivery and collection services.
Clinical trials are no longer limited to investigator sites but are now conducted in patients' homes, where they receive treatment and have blood samples taken for shipping. This approach requires drug delivery and sample collection services to be provided at the patient's doorstep.
To meet these demands, sponsor firms are outsourcing clinical trial activities to specialized providers to improve efficiency and reduce costs.
The increasing prevalence of chronic diseases, an aging population, and the emergence of Asian countries as key players in home healthcare are expected to drive further market expansion.
Asia-Pacific is experiencing significant growth
Asia-Pacific, particularly East and South Asia, is experiencing significant growth due to increasing healthcare needs and government funding for research. The demand for medications is rising due to the growing elderly population, which is also driving the clinical trial logistics market in the region. Major pharmaceutical companies are outsourcing their drug development services to countries like India, Malaysia, China, and Singapore, further fueling this market growth.
Patients are now comparing home care services to those offered by other industries like entertainment, banking, and retail.
While samples for pathological tests can be collected at home, physical visits to testing centers are still preferred for X-rays and ultrasounds. Although the trend of home sample collection is welcomed, service providers need to be adaptable to meet customer needs.
Clinical Trial Logistics Industry Overview
The clinical trials logistics market is fairly fragmented, with companies like Alamc Group, Catalent Inc., PCI Services, Parexel International Corporation, and Sharp Packaging Services are some of the major players in the market. The globalization of clinical trials, rising investments in R&D for clinical trials in the North American region, and rising strategic choices such as partnerships and collaboration for clinical trial services are some of the major factors contributing to the growth of the market.
Clinical Trial Logistics Market Leaders
-
Alamc Group
-
Catalent Inc.
-
PCI Services
-
Parexel International Corporation
-
Sharp Packaging Services
*Disclaimer: Major Players sorted in no particular order
Clinical Trial Logistics Market News
February 2024: Catalent Inc., a leader in enabling the development and supply of better treatments for patients worldwide, and Novo Holdings, a holding and investment company responsible for managing the assets and wealth of the Novo Nordisk Foundation, announced that they entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at USD 16.5 billion on an enterprise value basis.
October 2023: Aldena Therapeutics, a private biotech company pioneering siRNA-based therapies for dermatological indications, has chosen PCI Pharma Services (PCI), a world-leading global contract development and manufacturing organization (CDMO) to formulate, package, and distribute ALD-102, a siRNA-based investigational injectable treatment for inflammatory dermatological conditions, all under one roof at PCI’s San Diego facility.
Clinical Trial Logistics Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET INSIGHTS & DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Ageing Population
- 4.2.2 Expanding Number of Medical Care Suppliers
-
4.3 Market Restraints
- 4.3.1 High Cost in Managing Logistics
- 4.4 Market Opportunities
- 4.5 Value Chain / Supply Chain Analysis
-
4.6 Porter's Five Forces Analysis
- 4.6.1 Threat of New Entrants
- 4.6.2 Bargaining Power of Buyers/Consumers
- 4.6.3 Bargaining Power of Suppliers
- 4.6.4 Threat of Substitute Products
- 4.6.5 Intensity of Competitive Rivalry
- 4.7 Technological Snapshot
- 4.8 Government Regulations & Key Initiatives
- 4.9 Impact of Covid-19 on the Market
5. MARKET SEGMENTATION
-
5.1 Type Of Services
- 5.1.1 Delivery Of Medication
- 5.1.2 Pickup Of Specimens
- 5.1.3 Drug/Ancillary Supply Returns
-
5.2 By Region
- 5.2.1 North America
- 5.2.2 Asia-Pacific
- 5.2.3 Europe
- 5.2.4 South America
- 5.2.5 Middle East & Africa
6. COMPETITIVE LANDSCAPE
- 6.1 Market Competition Overview
-
6.2 Company Profiles
- 6.2.1 Alamc Group
- 6.2.2 Catalent Inc.
- 6.2.3 PCI Services
- 6.2.4 Parexel International Corporation
- 6.2.5 Sharp Packaging Services
- 6.2.6 Biocair
- 6.2.7 O&M Movianto
- 6.2.8 Klifo A/S
- 6.2.9 Thermo Fisher Scientific Inc.
- 6.2.10 Capsugel
- 6.2.11 UDG Healthcare Plc.
- 6.2.12 DHL
- 6.2.13 Bilcare Limited
- 6.2.14 PRA Health Sciences Inc.
- 6.2.15 Eurofins Scientific*
- *List Not Exhaustive
- 6.3 Other Companies
7. FUTURE OF THE MARKET
8. APPENDIX
** Subject To AvailablityClinical Trial Logistics Industry Segmentation
Clinical trial logistics is a service responsible for providing the necessary logistics for conducting clinical studies on medical devices or drugs in accordance with established protocols and relevant regulatory standards. The Clinical Trial Logistics Market is segmented by Type of Services (Delivery of Medication, Pickup of Specimens and Drug/Ancillary Supply Returns) and by Region (North America, South America, Europe, Asia-Pacific, and Middle East & Africa). The Report Offers Market Size and Forecast Values (USD) for all the Above Segments.
| Type Of Services | Delivery Of Medication |
| Pickup Of Specimens | |
| Drug/Ancillary Supply Returns | |
| By Region | North America |
| Asia-Pacific | |
| Europe | |
| South America | |
| Middle East & Africa |
Clinical Trial Logistics Market Research FAQs
How big is the Clinical Trial Logistics Market?
The Clinical Trial Logistics Market size is expected to reach USD 170.49 billion in 2024 and grow at a CAGR of 5.80% to reach USD 198.42 billion by 2029.
What is the current Clinical Trial Logistics Market size?
In 2024, the Clinical Trial Logistics Market size is expected to reach USD 170.49 billion.
Who are the key players in Clinical Trial Logistics Market?
Alamc Group, Catalent Inc., PCI Services, Parexel International Corporation and Sharp Packaging Services are the major companies operating in the Clinical Trial Logistics Market.
Which is the fastest growing region in Clinical Trial Logistics Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Clinical Trial Logistics Market?
In 2024, the North America and Europe accounts for the largest market share in Clinical Trial Logistics Market.
What years does this Clinical Trial Logistics Market cover, and what was the market size in 2023?
In 2023, the Clinical Trial Logistics Market size was estimated at USD 160.60 billion. The report covers the Clinical Trial Logistics Market historical market size for years: 2020, 2021, 2022 and 2023. The report also forecasts the Clinical Trial Logistics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Clinical Trial Logistics Industry Report
Statistics for the 2024 Clinical Trial Logistics market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Clinical Trial Logistics analysis includes a market forecast outlook for 2024 to (2024to2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
